Chengzhong Cai Source Confirmed
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
National Center for Toxicological Research
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Chengzhong Cai's research focuses on the application of mass spectrometry for early disease screening and the investigation of molecular mechanisms underlying disease progression. His recent work includes utilizing urine protein enrichment mass spectrometry to develop a model for accurate early screening of prostate cancer. Additionally, Cai has investigated the role of the importin beta superfamily member RanBP17 in cell proliferation and its association with patient survival in HPV+ HNSCC. He has also explored the prediction of oncology drug-induced cardiotoxicity using induced pluripotent stem cell-derived cardiomyocytes, with a proof-of-concept study involving doxorubicin. Cai's scholarship metrics include an h-index of 11, with 26 total publications and 402 citations. He has collaborated with several researchers at the National Center for Toxicological Research, including Vikrant Vijay, William B. Mattes, Katy S Papineau, and Lijun Ren.
Metrics
- h-index: 11
- Publications: 26
- Citations: 402
Selected Publications
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin (2024) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics